Login / Signup

Pick the best of both glucose and lipid metabolism.

Tatsunori ShimizuYuya TakahashiHiroki FujitaHironori Waki
Published in: Journal of diabetes investigation (2022)
Isthmin-1 is an adipokine that has a potent glucose-lowering effect by stimulating a common intracellular signaling pathway with insulin through a distinct receptor and has an inhibitory effect on lipogenesis in the liver, whereas insulin has the opposite effect. Isthmin-1 is expected to have clinical benefits in the treatment of diabetes.
Keyphrases
  • type diabetes
  • signaling pathway
  • glycemic control
  • cardiovascular disease
  • blood glucose
  • epithelial mesenchymal transition
  • adipose tissue
  • metabolic syndrome
  • fatty acid